Healthcare - Press Releases

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global blood marketsize is estimated to grow by USD 2.60 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 5.94% during the forecast period. Rising number of hospitals and blood banksis driving market growth,with a trend towardsrising awareness about blood donation. However,low availability of blood storage/transfusion facilities in rural areas poses a challenge. Key market players include Abbott Laboratories, AXO Science, BAG Health Care GmbH, Becton Dickinson and Co., Bio Rad Laboratories Inc., Cardinal Health Inc., CSL Ltd., Danaher Corp., DIAGAST SAS, F. Hoffmann La Roche Ltd., Grifols SA, Haemonetics Corp., Medtronic Plc, Merck KGaA, Mesa Laboratories Inc., Nipro Corp., QuidelOrtho Corp., Rapid Labs Ltd., Terumo Corp., Thermo Fisher Scientific Inc., and Werfenlife SA.

PALO ALTO, Calif., Feb. 6, 2025 /PRNewswire/ -- Glooko, Inc., a global integrated digital health company connecting patients, providers, biopharma, and medical device partners, and Innovation Zed, a pioneering developer of connected add-on devices for drug delivery devices, today announced a strategic partnership to develop and deploy digital companion apps with the adaptive DOSE platform hardware add-on technology for injectable therapies. This collaboration aims to revolutionize the management of injectable medications by providing comprehensive connectivity and data capture solutions for dosing, storage, and injection techniques.

LONDON, Feb. 6, 2025 /PRNewswire/ --Inizio, a commercialization partner for health and life science companies, has today announced the appointment of Colin Stanley as Chief Commercial Officer (CCO), Remco op den Kelder as President of Inizio Advisory and Jim Sage as President of Inizio Engage.

LONDON, 6. Februar 2025 /PRNewswire/ -- Inizio, ein Vermarktungspartner fr Gesundheits- und Biowissenschaftsunternehmen, hat heute die Ernennung von Colin Stanley zum Chief Commercial Officer (CCO), Remco op den Kelder zum Prsidenten von Inizio Advisory und Jim Sage zum Prsidenten von Inizio Engage bekannt gegeben.

LONDRES, 6 fvrier 2025 /PRNewswire/ -- Inizio, un partenaire de commercialisation pour les entreprises du secteur de la sant et des sciences de la vie, a annonc aujourd'hui la nomination de Colin Stanley au poste de Chief Commercial Officer (CCO), de Remco op den Kelder au poste de prsident d'Inizio Advisory et de Jim Sage au poste de prsident d'Inizio Engage.

Free Our Sports is a campaign of Alcohol Justice focused on ending the toxic relationship between alcohol advertising and sports. Alcohol Justice logo. (PRNewsFoto/Alcohol Justice)

Free Our Sports (Liberen nuestros deportes) es una campaa de Alcohol Justice con el objetivo de ponerle fin a la relacin txica entre las publicidades de bebidas alcohlicas y los deportes. Alcohol Justice logo. (PRNewsFoto/Alcohol Justice)

NEW YORK, 6 fvrier 2025 /PRNewswire/ --Stax LLC, une socit de conseil en stratgie mondiale spcialise dans la due diligence commerciale, la cration de valeur et la planification de sortie pour les socits de capital-investissement, les socits finances par le capital-investissement, les fonds spculatifs et les banques d'investissement, a le plaisir d'annoncer la nomination d'Adam Thorpe au poste de directeur gnral dans son bureau de Londres. ce titre, Adam dirigera le secteur vertical des soins de sant de l'entreprise dans la rgion EMEA.

NEW YORK, Feb. 6, 2025 /PRNewswire/ --Stax LLC, a global strategy consulting firm specializing in commercial due diligence, value creation, and exit planning for private equity firms, PE-backed companies, hedge funds, and investment banks, is pleased to announce the appointment of Adam Thorpe as a Managing Director in its London office. In this role, Adam will lead the firm's EMEA healthcare vertical.

NEW YORK, 6 februari 2025 /PRNewswire/ --Stax LLC, een wereldwijd strategieadviesbureau gespecialiseerd in commercieel due diligence-onderzoek, waardecreatie en exitplanning voor private equity-ondernemingen, PE-bedrijven, hedgefondsen en investeringsbanken, kondigt met genoegen aan dat het Adam Thorpe heeft benoemd tot Managing Director voor het kantoor in Londen. In deze rol zal Adam leiding geven aan de gezondheidszorgvertical in EMEA.

NEW YORK, 6. Februar 2025 /PRNewswire/ -- Stax LLC, ein globales Strategieberatungsunternehmen, das sich auf kommerzielle Due-Diligence-Prfungen, Wertschpfung und Exit-Planung fr Private-Equity-Firmen, PE-untersttzte Unternehmen, Hedgefonds und Investmentbanken spezialisiert hat, freut sich, die Ernennung von Adam Thorpe zum Managing Director in seinem Londoner Bro bekannt zu geben. In dieser Funktion wird Adam den Bereich EMEA Healthcare Vertical leiten.

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global analytical standards marketsize is estimated to grow by USD 657.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Rapid growth in life science industryis driving market growth,with a trend towardsincreasing adoption of custom standards. However,limited shelf life of analytical standards poses a challenge. Key market players include AccuStandard Inc., Agilent Technologies, Inc., Cayman Chemical, Chiron AS, GFS Chemicals, Inc., LGC Limited, Mallinckrodt, Merck KGaA, PerkinElmer, Inc., Restek Corporation, Ricca Chemical Company, SPEX CertiPrep, The United States Pharmacopeial Convention, Thermo Fisher Scientific Inc., Waters Corporation

COPENHAGEN, Denmark and LONDON, Feb. 5, 2025 /PRNewswire/ -- Liva Healthcare ("Liva" or "the Company"), a digital health technology platform with human-led therapeutic intervention programmes that deliver best-in-class outcomes for lifestyle-related chronic diseases, today announces that it has acquired UK-based Discover Momenta, including subsidiary Momenta Newcastle, for an undisclosed sum. The acquisition of Momenta is part of Liva's growth strategy as it emerges as a major international provider of evidence-based therapeutic lifestyle interventions.

HELSINKI, Feb. 5, 2025 /PRNewswire/ -- UPM-Kymmene CorporationStock Exchange Release (Other information disclosed according to the rules of the Exchange) 5 February 2025 at 09:50 EET

NEW YORK and LONDON and BERLIN and TOKYO, Feb. 4, 2025 /PRNewswire/ --Sony Group Corporation (Sony) and Nature are proud to announce the inaugural recipients of the Sony Women in Technology Award with Nature, honoring outstanding early to mid-career women researchers who are spearheading breakthroughs for the betterment of society and the planet in the field of technology (science, engineering, and mathematics). The award grants each winner a prize of $250,000 to support and accelerate their technological research.

NEW YORK, Feb. 4, 2025 /PRNewswire/ --Report on how AI is redefining market landscape - The global medical tourism marketsize is estimated to grow by USD 85.9 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.11% during the forecast period.Aavailability of low-cost treatment options is driving market growth, with a trend towards growing focus on technological advancements. However, lack of advanced infrastructure in developing nations poses a challenge. Key market players include Anadolu Medical Center, Apollo International Ltd., Asian Heart Institute, Asian institute of medical sciences, Asklepios Kliniken GmbH and Co. KGaA, Athina Global Health, Bangkok Chain Hospital Public Co. Ltd, Bangkok Dusit Medical Services Public Co. Ltd., BNH Medical Centre Co. Ltd., Bumrungrad Hospital Public Co. Ltd, Clalit Research Institute, Clemenceau Medical Center, Dr. B. L. Kapur Memorial Hospital, Global Health Ltd., IHH Healthcare Berhad., Min Sheng General Hospital, Raffles Medical Group Ltd, Spire Healthcare Group Plc, The Cleveland Clinic Foundation, and The Johns Hopkins Health System Corp..

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The Commercial and residential cleaning services market in USsize is estimated to grow by USD 37.8 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 5.9% during the forecast period. Rising popularity of multifamily dwellings in USis driving market growth,with a trend towardsincreasing number of strategic alliances. However,fluctuations in labor wages poses a challenge. Key market players include ABM Industries Inc., Anago Cleaning Systems Inc., Bonus Building Care, Buildingstars, City Wide Cleaning Services, CleanNet USA Inc., Coit Services Inc., Coverall North America Inc., Handy, Harvard Maintenance, ISS AS, JAN PRO Franchising International Inc, Jani King International Inc., MaidPro, Neighborly Co., OFFICE PRIDE, Stratus Building Solutions, The Cleaning Authority LLC., The ServiceMaster Co. LLC, and Vanguard Cleaning Systems Inc..

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Report on how AI is redefining market landscape - The global online therapy services marketsize is estimated to grow by USD 64.09 billion from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 53.9% during the forecast period. Surging adoption of smartphones coupled with increased preference for online servicesis driving market growth,with a trend towardsgrowing popularity of online health services. However,privacy concerns related to patient mental health issues poses a challenge. Key market players include 7 Cups of Tea Co., American Well Corp., BreakThrough Counseling Services, Calmerry, CareMe Health, Cerebral Inc., Doctor On Demand Inc., DocVita Inc., Felicity, Heart it out, HopeQure Wellness Solutions Pvt. Ltd., Manastha, MDLIVE Inc., Mental Fuel Inc., Mind Voyage, ReGain, TALKSPACE INC., Teladoc Health Inc., ThriveTalk, and Thriveworks Counseling.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 4, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immune-oncology and immunology, today announced that the National Medical Products Administration (NMPA) of China has approved the Investigational New Drug (IND) applicationfor HBM9378/SKB378 (also known as WIN378), a fully human antibody targeting thymic stromal lymphopoietin (TSLP), forthe treatment ofchronic obstructive pulmonary disease (COPD).

TAICHUNG, Feb. 5, 2025 /PRNewswire/ -- Healthcare Expo Taiwan is a professional-oriented exposition involving healthcare, information/communication, technology, biopharmaceutical and medical device industries. Attended by healthcare professionals from all over the world, the Expo showcases the latest developments and trends in healthcare technology in Taiwan. China Medical University (CMU) and Healthcare System unveiled groundbreaking advancements in AI-driven drug discovery and cancer therapy at the latest 8th Healthcare Expo. These achievements cement CMU and Healthcare System's position as a global leader in healthcare innovation, setting new benchmarks for the biomedical industry.

NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The globalproton pump inhibitors (PPIs) marketsize is estimated to grow by USD 819.5 million from 2025-2029, according to Technavio. The market is estimated to grow at a CAGR of 4.7% during the forecast period. Reformulation of drugsis driving market growth,with a trend towardsgrowing geriatric population. However,increasing lawsuits against PPIs poses a challenge. Key market players include Amgen Inc., AstraZeneca Plc, Aurobindo Pharma Ltd., Bausch Health Companies Inc., Bayer AG, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., Eli Lilly and Co., Glenmark Pharmaceuticals Ltd., Johnson and Johnson Inc., Perrigo Co. Plc, Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., The Procter and Gamble Co., and Zydus Lifesciences Ltd..

STOCKHOLM, Feb. 5, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the fourth quarter 2024.

STOCKHOLM, Feb. 5, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi) today announced its report for the fourth quarter 2024.

MILAN, Feb. 5, 2025 /PRNewswire/ -- Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA). The IDE clearance paves the way for Newronika to initiate a pivotal U.S. clinical trial to evaluate the safety and efficacy of its adaptive DBS system for patients with movement disorders, including Parkinson's disease.

MAILAND, 5. Februar 2025 /PRNewswire/ --Newronika, der Entwickler der bahnbrechenden adaptiven Technologie zur Tiefenhirnstimulation, ist stolz darauf, den Erhalt einer IDE (Investigational Device Exemption) von der US-amerikanischen Food and Drug Administration (FDA) bekannt zu geben. Die IDE-Freigabe ebnet Newronika den Weg fr den Beginn einer entscheidenden klinischen Studie in den USA, um die Sicherheit und Wirksamkeit seines adaptiven DBS-Systems fr Patienten mit Bewegungsstrungen, einschlielich der Parkinson-Krankheit, zu bewerten.